Shares in GSK opened 1.9-percent lower in London following the results update. Over-the-counter treatment Zantac, known also by its non-commercial name ranitidine, was manufactured by several ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

In March, they declined, and the amended complaint was filed on May 20. [3] Zantac was one of GSK’s most successful products, the first prescription drug in history to reach $1 billion in sales ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

Steady growth from vaccines should reduce the volatility from patent losses in the prescription drug business ... We have factored in expenses for Zantac litigation. GSK’s next-generation ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

On Tuesday, U.S. District Judge Brian Cogan in New York dismissed key consumer claims in the multidistrict litigation against ...

“Ranitidine, used for acid reflux ... readers should first determine if their prescription was included in the recall,” Johnson-Arbor said. If your medication is part of the recall, the ...

With a portfolio of iconic brands, such as Allegra, Doliprane, and Dulcolax, Opella is already the third-largest business worldwide in the over-the-counter and vitamins ... As is customary with ...